Cargando…
Early detection and staging of chronic liver diseases with a protein MRI contrast agent
Early diagnosis and noninvasive detection of liver fibrosis and its heterogeneity remain as major unmet medical needs for stopping further disease progression toward severe clinical consequences. Here we report a collagen type I targeting protein-based contrast agent (ProCA32.collagen1) with strong...
Autores principales: | Salarian, Mani, Turaga, Ravi Chakra, Xue, Shenghui, Nezafati, Maysam, Hekmatyar, Khan, Qiao, Jingjuan, Zhang, Yinwei, Tan, Shanshan, Ibhagui, Oluwatosin Y., Hai, Yan, Li, Jibiao, Mukkavilli, Rao, Sharma, Malvika, Mittal, Pardeep, Min, Xiaoyi, Keilholz, Shella, Yu, Liqing, Qin, Gengshen, Farris, Alton Brad, Liu, Zhi-Ren, Yang, Jenny J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6820552/ https://www.ncbi.nlm.nih.gov/pubmed/31664017 http://dx.doi.org/10.1038/s41467-019-11984-2 |
Ejemplares similares
-
Functional MRI Signal Complexity Analysis Using Sample Entropy
por: Nezafati, Maysam, et al.
Publicado: (2020) -
Early Detection and
Staging of Lung Fibrosis Enabled
by Collagen-Targeted MRI Protein Contrast Agent
por: Ibhagui, Oluwatosin Y., et al.
Publicado: (2023) -
Chemokine receptor 4 targeted protein MRI contrast agent for early detection of liver metastases
por: Tan, Shanshan, et al.
Publicado: (2020) -
GRPR-targeted Protein Contrast Agents for Molecular Imaging of Receptor Expression in Cancers by MRI
por: Pu, Fan, et al.
Publicado: (2015) -
Targeting integrin αvβ3 by a rationally designed protein for chronic liver disease treatment
por: Turaga, Ravi Chakra, et al.
Publicado: (2021)